Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OTCMKTS:OXYS

OxySure Therapeutics (OXYS) Stock Price, News & Analysis

About OxySure Therapeutics Stock (OTCMKTS:OXYS)

Advanced Chart

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
N/A
52-Week Range
$0.00
$0.15
Volume
53,810 shs
Average Volume
135,131 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OXYS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OxySure Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OXYS Stock News Headlines

Altamira Therapeutics Continues Strategy of Divestiture
See More Headlines

OXYS Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that OxySure Therapeutics investors own include IDEXX Laboratories (IDXX), Enterprise GP (EPE), (CDII) (CDII), JetBlue Airways (JBLU), Unrivaled Brands (TRTC) and 102535 (CMM.V) (CMM).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:OXYS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:OXYS) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners